Clinical trial
Creatine in Treating Patients With Cancer-Associated Weight Loss
NCT00081250 · Alliance for Clinical Trials in Oncology, Other · Completed
Key facts
| NCT number | NCT00081250 |
|---|---|
| Title | Creatine in Treating Patients With Cancer-Associated Weight Loss |
| Official title | Phase III Double-Blind, Placebo-Controlled Randomized Comparison of Creatine for Cancer-Associated Weight Loss |
| Lead sponsor | Alliance for Clinical Trials in Oncology, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Anorexia, Cachexia, Unspecified Adult Solid Tumor, Protocol Specific, Weight Changes |
| Intervention type | Dietary Supplement, Other |
| Interventions | creatine monohydrate, placebo |
| Enrollment | 300 |
| Start date | Dec 1, 2004 |
| Primary completion | Dec 1, 2007 |
| Completion | Jul 1, 2017 |
| First posted | Apr 8, 2004 |
| Last update posted | Apr 29, 2020 |
| Countries | United States |
At a glance
- 100–999 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: